Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway.
Plasticity of vascular smooth muscle cells (VSMCs) plays a central role in the onset and progression of proliferative vascular diseases. In adult tissue, VSMCs exist in a physiological contractile-quiescent phenotype, which is defined by lack of the ability of proliferation and migration, while high...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4398430?pdf=render |
id |
doaj-84a6b7bb9e4f4682820201e3cc8df431 |
---|---|
record_format |
Article |
spelling |
doaj-84a6b7bb9e4f4682820201e3cc8df4312020-11-25T01:27:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012257710.1371/journal.pone.0122577Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway.Shuang ChenBaoqin LiuDehui KongSi LiChao LiHuaqin WangYingxian SunPlasticity of vascular smooth muscle cells (VSMCs) plays a central role in the onset and progression of proliferative vascular diseases. In adult tissue, VSMCs exist in a physiological contractile-quiescent phenotype, which is defined by lack of the ability of proliferation and migration, while high expression of contractile marker proteins. After injury to the vessel, VSMC shifts from a contractile phenotype to a pathological synthetic phenotype, associated with increased proliferation, migration and matrix secretion. It has been demonstrated that PDGF-BB is a critical mediator of VSMCs phenotypic switch. Atorvastatin calcium, a selective inhibitor of 3-hydroxy-3-methyl-glutaryl l coenzyme A (HMG-CoA) reductase, exhibits various protective effects against VSMCs. In this study, we investigated the effects of atorvastatin calcium on phenotype modulation of PDGF-BB-induced VSMCs and the related intracellular signal transduction pathways. Treatment of VSMCs with atorvastatin calcium showed dose-dependent inhibition of PDGF-BB-induced proliferation. Atorvastatin calcium co-treatment inhibited the phenotype modulation and cytoskeleton rearrangements and improved the expression of contractile phenotype marker proteins such as α-SM actin, SM22α and calponin in comparison with PDGF-BB alone stimulated VSMCs. Although Akt phosphorylation was strongly elicited by PDGF-BB, Akt activation was attenuated when PDGF-BB was co-administrated with atorvastatin calcium. In conclusion, atorvastatin calcium inhibits phenotype modulation of PDGF-BB-induced VSMCs and activation of the Akt signaling pathway, indicating that Akt might play a vital role in the modulation of phenotype.http://europepmc.org/articles/PMC4398430?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shuang Chen Baoqin Liu Dehui Kong Si Li Chao Li Huaqin Wang Yingxian Sun |
spellingShingle |
Shuang Chen Baoqin Liu Dehui Kong Si Li Chao Li Huaqin Wang Yingxian Sun Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway. PLoS ONE |
author_facet |
Shuang Chen Baoqin Liu Dehui Kong Si Li Chao Li Huaqin Wang Yingxian Sun |
author_sort |
Shuang Chen |
title |
Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway. |
title_short |
Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway. |
title_full |
Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway. |
title_fullStr |
Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway. |
title_full_unstemmed |
Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway. |
title_sort |
atorvastatin calcium inhibits phenotypic modulation of pdgf-bb-induced vsmcs via down-regulation the akt signaling pathway. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2015-01-01 |
description |
Plasticity of vascular smooth muscle cells (VSMCs) plays a central role in the onset and progression of proliferative vascular diseases. In adult tissue, VSMCs exist in a physiological contractile-quiescent phenotype, which is defined by lack of the ability of proliferation and migration, while high expression of contractile marker proteins. After injury to the vessel, VSMC shifts from a contractile phenotype to a pathological synthetic phenotype, associated with increased proliferation, migration and matrix secretion. It has been demonstrated that PDGF-BB is a critical mediator of VSMCs phenotypic switch. Atorvastatin calcium, a selective inhibitor of 3-hydroxy-3-methyl-glutaryl l coenzyme A (HMG-CoA) reductase, exhibits various protective effects against VSMCs. In this study, we investigated the effects of atorvastatin calcium on phenotype modulation of PDGF-BB-induced VSMCs and the related intracellular signal transduction pathways. Treatment of VSMCs with atorvastatin calcium showed dose-dependent inhibition of PDGF-BB-induced proliferation. Atorvastatin calcium co-treatment inhibited the phenotype modulation and cytoskeleton rearrangements and improved the expression of contractile phenotype marker proteins such as α-SM actin, SM22α and calponin in comparison with PDGF-BB alone stimulated VSMCs. Although Akt phosphorylation was strongly elicited by PDGF-BB, Akt activation was attenuated when PDGF-BB was co-administrated with atorvastatin calcium. In conclusion, atorvastatin calcium inhibits phenotype modulation of PDGF-BB-induced VSMCs and activation of the Akt signaling pathway, indicating that Akt might play a vital role in the modulation of phenotype. |
url |
http://europepmc.org/articles/PMC4398430?pdf=render |
work_keys_str_mv |
AT shuangchen atorvastatincalciuminhibitsphenotypicmodulationofpdgfbbinducedvsmcsviadownregulationtheaktsignalingpathway AT baoqinliu atorvastatincalciuminhibitsphenotypicmodulationofpdgfbbinducedvsmcsviadownregulationtheaktsignalingpathway AT dehuikong atorvastatincalciuminhibitsphenotypicmodulationofpdgfbbinducedvsmcsviadownregulationtheaktsignalingpathway AT sili atorvastatincalciuminhibitsphenotypicmodulationofpdgfbbinducedvsmcsviadownregulationtheaktsignalingpathway AT chaoli atorvastatincalciuminhibitsphenotypicmodulationofpdgfbbinducedvsmcsviadownregulationtheaktsignalingpathway AT huaqinwang atorvastatincalciuminhibitsphenotypicmodulationofpdgfbbinducedvsmcsviadownregulationtheaktsignalingpathway AT yingxiansun atorvastatincalciuminhibitsphenotypicmodulationofpdgfbbinducedvsmcsviadownregulationtheaktsignalingpathway |
_version_ |
1725107545039699968 |